Company Filing History:
Years Active: 2016-2018
Title: Innovations of Lung-Huang Kuo
Introduction
Lung-Huang Kuo is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for synthesizing important compounds. With a total of 3 patents to his name, Kuo's work has had a meaningful impact on medical science.
Latest Patents
Kuo's latest patents include a process for the production of Fondaparinux sodium. This invention provides improved methods for preparing Fondaparinux sodium by converting a compound of formula ABCDE4 at a reaction pH of no more than about 9.0. Additionally, the invention includes intermediates for the synthesis of Fondaparinux sodium. Another significant patent is for the preparation of abiraterone and its intermediates. This invention outlines processes for preparing abiraterone and includes intermediates represented by a compound of formula (IV), where R signifies a hydroxy-protecting group.
Career Highlights
Lung-Huang Kuo is currently associated with Scinopharm Taiwan, Ltd., a company known for its focus on pharmaceutical development. His work at Scinopharm has allowed him to explore innovative solutions in drug synthesis and production.
Collaborations
Kuo has collaborated with notable colleagues such as Shang-Hong Chen and Li-Ting Wang. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Lung-Huang Kuo's contributions to pharmaceutical innovations through his patents demonstrate his expertise and commitment to advancing medical science. His work continues to influence the field and improve drug development processes.